Senior insider sale
Chief Medical Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$2.69M
33K shares
What this filing means
DAMBKOWSKI CARL plans to sell 33K shares of APOGEE THERAPEUTICS, INC. valued at approximately $2.69M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001950047-26-004130
Officer· Chief Medical Officer
Since Mar 2026
33K
Shares to sell
$2.69M
Approx. market value
22K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
5/6/2026
16.50KRestricted Stock Awards
N/A
12/14/2022
5.50KTotal acquired22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/6/2026 | Exercise of Stock Options Cash | 16.50K | — |
12/14/2022 | Restricted Stock Awards N/A | 5.50K | — |
| Total | 22K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.50K
Market value
$466.6K
4/1/2026
—Completed
Units to sell
5.50K
Market value
$390.8K
3/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22K
Market value
$1.83M
5/6/2026
Total
Units
33K
Value
$2.69M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 5.50K | $466.6K | — | Completed |
3/4/2026 | 5.50K | $390.8K | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 22K | $1.83M | NASDAQ | Planned |
| Total | 33K | $2.69M | ||